Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
---|
03/24/1998 | CA1339780C Antiviral phosphonomethoxyalkylene purine and pyrimidine derivatives |
03/23/1998 | CA2216222A1 1-carba-(dethia)-cephalosporin derivatives |
03/23/1998 | CA2196502A1 Compositions and methods for treatment of streptococcus pneumoniae infection |
03/20/1998 | CA2185950A1 Process for preparing intermediates for thrombin inhibitors |
03/19/1998 | WO1998011229A2 Histidine-tagged shiga toxins, toxoids, and protein fusions with such toxins and toxoids, methods for the purification and preparation thereof |
03/19/1998 | WO1998011137A1 Use of proteins as anti-retroviral agents |
03/19/1998 | WO1998011133A1 New picornaviruses, vaccines and diagnostic kits |
03/19/1998 | WO1998011128A1 Modified aminoacids, pharmaceuticals containing these compounds and method for their production |
03/19/1998 | WO1998011109A1 Novel tricyclic compounds for the inhibition of the ice/ced-3 protease family of enzymes |
03/19/1998 | WO1998011108A1 Carbapenem antibacterial compounds, compositions containing such compounds and methods of treatment |
03/19/1998 | WO1998011073A1 8-hydroxy-7-substituted quinolines as anti-viral agents |
03/19/1998 | WO1998010792A1 Immune direction therapy |
03/19/1998 | WO1998010788A1 Staphylococcus aureus antigen |
03/19/1998 | WO1998010787A2 Pharmaceutical compositions for the treatment of immune disorders |
03/19/1998 | WO1998010783A1 Muc-1 as an immunosuppressive therapeutic agent for the treatment of inflammatory and autoimmune conditions |
03/19/1998 | WO1998010782A1 Antifungal combination therapy |
03/19/1998 | WO1998010773A1 Pharmaceutical compositions with antimicrobial activity |
03/19/1998 | WO1998010766A1 METHOD OF INHIBITING BIOSYNTHESIS OF EIf5A |
03/19/1998 | WO1998010764A1 Pharmaceutical composition for treating viral diseases |
03/19/1998 | WO1998010761A1 Carbapenem antibacterial compounds, compositions containing such compounds and methods of treatment |
03/19/1998 | WO1998010749A1 Protein-lipid vesicles and autogenous vaccine comprising the same |
03/19/1998 | WO1998010748A1 Liposomes |
03/19/1998 | WO1998010747A1 Immunomodulatory formulation |
03/19/1998 | WO1998010746A1 Compositions and methods for topical application of therapeutic agents |
03/19/1998 | WO1998010742A1 Composition base for topical therapeutic and cosmetic preparations |
03/19/1998 | WO1998010656A1 Use of algae extract as antibacterial and/or antifungal agent and composition containing same |
03/19/1998 | WO1998010652A1 NOVEL trpS |
03/19/1998 | WO1998006265A3 Treatment of fungal infections using a combination of an anti-fungal compound and an n-alkyl-heterocyclic compound, especially n-dodecyl-morpholine |
03/19/1998 | CA2265887A1 Histidine-tagged shiga toxins, toxoids, and protein fusions with such toxins and toxoids, methods for the purification and preparation thereof |
03/19/1998 | CA2265885A1 Pharmaceutical compositions for the treatment of immune disorders |
03/19/1998 | CA2265542A1 Pharmaceutical composition for treating viral diseases |
03/19/1998 | CA2265445A1 Use of proteins as anti-retroviral agents |
03/19/1998 | CA2264748A1 Muc-1 as an immunosuppressive therapeutic agent for the treatment of inflammatory and autoimmune conditions |
03/19/1998 | CA2264646A1 Protein-lipid vesicles and autogenous vaccine comprising the same |
03/19/1998 | CA2264605A1 Carbapenem antibacterial compounds, compositions containing such compounds and methods of treatment |
03/19/1998 | CA2264147A1 Carbapenem antibacterial compounds, compositions containing such compounds and methods of treatment |
03/19/1998 | CA2262818A1 Modified amino acids, pharmaceuticals containing these compounds and methods for their production |
03/19/1998 | CA2262786A1 8-hydroxy-7-substituted quinolines as anti-viral agents |
03/19/1998 | CA2237557A1 Composition base for topical therapeutic and cosmetic preparations |
03/19/1998 | CA2237314A1 Novel tricyclic compounds for the inhibition of the ice/ced-3 protease family of enzymes |
03/18/1998 | EP0829487A2 Polyene antibiotics 3874 H1 to H6, method for their preparation and use |
03/18/1998 | EP0829486A2 Polyene antibiotics, 3874 H1 to H6, method for their preparation and use |
03/18/1998 | EP0829480A2 Tetrazolyl-substituted quinuclidines as substance P antagonists |
03/18/1998 | EP0828839A1 Animal gene therapy |
03/18/1998 | EP0828757A1 Helicobacter pylori antigens and vaccine compositions |
03/18/1998 | EP0828756A2 Diagnosis of, and vaccination against, a positive stranded rna virus using an isolated, unprocessed polypeptide |
03/18/1998 | EP0828750A1 Palladium catalyzed nucleoside modification methods using nucleophiles and carbon monoxide |
03/18/1998 | EP0828741A1 Spirocyclic and bicyclic diazinyl and carbazinyl oxazolidinones |
03/18/1998 | EP0828732A1 Peptidyl compounds and their therapeutic use |
03/18/1998 | EP0828721A1 2-amino-benzoxazinones for the treatment of viral infections |
03/18/1998 | EP0828715A1 N-oxides as antibacterial agents |
03/18/1998 | EP0828714A1 Method for making quinolone carboxylic acids or naphthyridine carboxylic acids in free base form |
03/18/1998 | EP0828520A1 Methods of screening compounds useful for prevention of infection or pathogenicity |
03/18/1998 | EP0828515A1 Antibacterial-wound healing compositions and methods for preparing and using same |
03/18/1998 | EP0828511A1 Vaccine composition containing polyribosylribitol phosphate and method for making same |
03/18/1998 | EP0828510A1 Abundant extracellular products and methods for their production and use |
03/18/1998 | EP0828502A2 Pharmaceutical compositions, based on etheric oils obtained from plants for use in the human and veterinary medical field |
03/18/1998 | EP0828493A1 4.4-(disubstituted)cyclohexan-1-ols-monomers and related compounds |
03/18/1998 | EP0828488A1 Isothiazolones |
03/18/1998 | EP0681586B1 Oligodeoxynucleotides containing 5-alkyl-, 5-(1-alkenyl)- and 5-(1-alkynyl)pyrimidines and pharmaceutical compositions containing such compounds |
03/18/1998 | EP0554418B1 Intestine colonizing lactobacilli |
03/18/1998 | CN1176662A Identification of genes |
03/18/1998 | CN1176659A A method for making heteromultimeric polypeptides |
03/18/1998 | CN1176658A Vaccine and antitoxin for treatment and prevention of C. difficile disease |
03/18/1998 | CN1176641A Derivatives of 3-pyrrolidylidene -2 -one -cephalosporines |
03/18/1998 | CN1176637A Piperazine-2, 5 -dione derivatives as modulators of multidrug resistance |
03/18/1998 | CN1176604A 乙肝疫苗 Hepatitis B vaccine |
03/18/1998 | CN1176598A Method and compositions for treating allergic rhinitis and other disorders using descarboethoxyloratadine |
03/18/1998 | CN1176252A Novel coumarin quinolone carboxylic acids and processes for preparation thereof |
03/18/1998 | CN1176250A HIV protease inhibitors useful for treatment of AIDS |
03/18/1998 | CN1176133A Medicine powder for tuberculosis |
03/18/1998 | CN1176101A N -(4 -aryl -thiazol -2 -yl) -sulphonamide derivatives and their use |
03/17/1998 | US5728874 Anti-HIV achiral polyurea oligomers, a process for creating them, formulations using them, and their use in the treatment of AIDS |
03/17/1998 | US5728846 Benzo 1,2-g!-chrom-3-ene and benzo 1,2-g!-thiochrom-3-ene derivatives |
03/17/1998 | US5728845 Immunotherapeutic nitriles |
03/17/1998 | US5728844 Immunotherapeutic agents |
03/17/1998 | US5728819 Secreted proteins and polynucleotides encoding them |
03/17/1998 | US5728731 Administering a polyamide oligomer to a patient to treat a herpes viral infection |
03/17/1998 | US5728728 Administering felbamate to human having sepsis, hiv dementia, meningitis or central nervous system vasculitis, which is a neuronal cell protecting antagonist of glycine site of n-methyl-d-aspartate receptor complex |
03/17/1998 | US5728718 Retroviral protease inhibitor; treatment of htlv |
03/17/1998 | US5728711 Antiulcer agents |
03/17/1998 | US5728710 Rapamycin derivatives |
03/17/1998 | US5728700 Sulfonamide compounds of azolones anti-helicobacter agents |
03/17/1998 | US5728686 Alkylxanthine phosphonates and alkylxanthine phosphine oxides and their use as pharmaceuticals |
03/17/1998 | US5728578 Peptide of the structural phosphoprotein (pp 150) of human cytomegalovirus, and DNA encoding said peptide |
03/17/1998 | US5728569 Inoculation of embryonated eggs, propagation, harvesting |
03/17/1998 | US5728541 Screening therapeutic or chemotherapeutic agents for efficacy as to a specific patient |
03/17/1998 | US5728521 Targeted cleavage of RNA using eukaryotic ribonuclease P and external guide sequence |
03/17/1998 | US5728520 Immunoreactive polypeptide compositions |
03/17/1998 | US5728518 Soluble complex of a poly- or oligonucleotide and a carrier |
03/17/1998 | US5728387 Structural gene of pneumococcal protein |
03/17/1998 | US5728386 Thermostable varicella zoster virus |
03/17/1998 | US5728369 Radioactive phosphorus labeling of proteins for targeted radiotherapy |
03/17/1998 | CA1339740C Alpha-glucosidase inhibitors |
03/17/1998 | CA1339739C Cephem compounds and processes for preparation thereof |
03/12/1998 | WO1998009992A2 HTm4, METHODS OF TREATMENT AND ASSAYS, AGONISTS AND ANTAGONISTS |
03/12/1998 | WO1998009980A1 Bh3 interacting domain death agonist |
03/12/1998 | WO1998009978A1 6-o-substituted ketolides having antibacterial activity |
03/12/1998 | WO1998009977A1 Tetrahydronapthalene derivatives and their therapeutic use |
03/12/1998 | WO1998009975A1 1,3-dicarboxylic germanium complex and its therapeutic use |